""
Press release |

MSF applauds US' leadership on waiving IP for COVID-19 vaccines

MSF applauds the Biden-Harris Administration’s decision to support waiving intellectual property protections for COVID-19 vaccines. Doing so will increase sufficient and timely access to these lifesaving medical tools as COVID-19 continues to ravage countries across the globe.

COVID-19
Read more
Photograph by Pierre-Yves Bernard

Latest news

Key publications

MSF Access Campaign work on COVID-19

Video thumbnail
MSF International President appeals to governments blocking landmark COVID-19 proposal
Video thumbnail
COVID-19: No patents or profiteering in a pandemic
Video thumbnail
No monopolies - Access to COVID-19 treatment
Video thumbnail
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
Video thumbnail
A Snapshot of the Access Campaign

What good is a breakthrough medicine if the people who need it can't afford it?

Lives over profit
20 Years of Advocacy in Action - JOIN US!

Our work

COVID-19
Drug-resistant infections
Diabetes
Hepatitis C
HIV/AIDS
Tropical & neglected diseases
Tuberculosis
Vaccines
Patents & intellectual property
Research & development

Read, watch, share